How to Value a Courier or Last-Mile Delivery Business

The last-mile delivery space has exploded in the past five years, and the valuation landscape is more fragmented than almost any sector I cover. A medical courier running STAT specimen deliveries for hospital systems gets valued very differently than an Amazon DSP running 40 vans out of a delivery station, which gets valued very differently than a regional same-day courier with a mix of contract and on-demand business. Same broad industry, completely different economics and buyer pools.

Let me walk through how each segment is actually valued and what drives the numbers up or down.

Contract-Based Courier: The Highest Multiples

Courier companies with dedicated contract routes — same customers, same routes, recurring monthly revenue — are valued at 3-6x EBITDA or 2-4x SDE for smaller operations. The upper end of that range goes to companies with multi-year contracts, diversified customers, and W-2 driver workforces.

The math on a typical contract courier: a company running 25 dedicated routes at $3,500-$5,000 per route per month generates $1M-$1.5M in annual revenue. With 55-65% going to driver labor and vehicle costs, EBITDA margins of 12-18% are typical, yielding $150K-$250K EBITDA. At 4-5x, that's a $600K-$1.25M business.

What pushes contract couriers toward the 5-6x range:

• Contract length and renewal rates. Three-year contracts with 90%+ renewal rates look like recurring revenue to buyers. Month-to-month arrangements get a discount.
• Customer diversification. No single customer above 15-20% of revenue. I've seen otherwise solid courier companies get hammered on valuation because one hospital system represents 40% of their routes — that's a concentration risk buyers will price in.
• W-2 vs. 1099 workforce. Companies using W-2 employee drivers are valued higher than 1099 independent contractor models — despite the higher labor cost — because the legal risk of IC misclassification has become real. California's AB5, the DOL's 2024 rule, and state-level enforcement actions have made 1099-heavy courier models a liability concern for sophisticated buyers.

Amazon DSP: A Unique (and Constrained) Category

Amazon Delivery Service Partners are a category unto themselves. There are roughly 3,500 DSPs in the US operating 100,000+ delivery vehicles. These businesses generate $2M-$8M in annual revenue depending on route count, with EBITDA margins of 8-15%. On paper, they look attractive — guaranteed volume from the world's largest e-commerce company.

The reality is more nuanced, and valuations reflect it. DSPs typically trade at 2-4x EBITDA, meaningfully below independent courier companies. Here's why:

Amazon controls pricing. Your per-package and per-route rates are set by Amazon and can change with 30 days notice. You have essentially zero pricing power. When Amazon decided to reduce per-package rates by $0.05-$0.10 in several markets in 2024, DSP margins compressed overnight with no recourse.

Single-customer dependency.100% of your revenue comes from Amazon. That's the ultimate customer concentration risk. Amazon can — and does — terminate DSP agreements, consolidate routes, or shift volume between delivery stations. You're building a business on someone else's platform.

Transferability is uncertain.Amazon must approve any ownership transfer. They've been known to reject buyers, delay approvals, or use the transition as an opportunity to renegotiate terms. This makes traditional M&A processes difficult and eliminates most institutional buyers.

That said, well-run DSPs in high-density markets do sell. A 40-van DSP generating $5M revenue and $500K EBITDA with strong Fantastic+ scores and low driver turnover might sell for $1.2M-$2M — roughly 2.5-4x EBITDA. The buyers are typically individuals looking to acquire an operating business, not strategic acquirers building platforms.

Medical Courier: The Premium Segment

Medical courier — transporting laboratory specimens, blood products, pharmaceuticals, medical records, and medical devices — commands the highest multiples in the courier industry at 4-7x EBITDA. The premium exists for clear reasons.

Regulatory barriers create moats. Medical couriers need HIPAA compliance programs, proper chain-of-custody documentation, temperature-controlled transport capability (cold chain for specimens and biologics), and often DOT hazmat certifications for certain biological materials. These requirements filter out general courier operators and create genuine barriers to entry.

Reliability is non-negotiable. When a hospital needs a STAT specimen transported to a reference lab, a 30-minute delay can affect patient outcomes. Medical couriers that maintain 99%+ on-time delivery rates with proper temperature documentation can charge $15-$25 per delivery vs. $8-$12 for general courier service. That reliability premium flows directly to margins.

Contract stickiness is exceptional. Hospital systems, reference labs (Quest Diagnostics, Labcorp), and pharmacy chains sign 3-5 year contracts and rarely switch providers because the qualification process is onerous. Customer retention rates of 95%+ are common in medical courier.

The active acquirers in medical courier include MedSpeed (the largest dedicated medical courier, PE-backed), Promedica Staffing's logistics division, and several regional players building scale. A medical courier doing $3M-$5M in revenue with hospital system contracts and cold chain capability is exactly what these buyers are looking for.

Technology as a Value Driver

In 2026, the technology stack of a courier operation meaningfully affects its valuation. Buyers are looking for:

• Route optimization software. Companies using platforms like Onfleet, Routific, or proprietary route optimization achieve 20-30% more deliveries per driver per day. That efficiency drops straight to the bottom line.
• Real-time tracking and proof of delivery. GPS tracking, photo proof of delivery, electronic signatures, and customer-facing tracking portals are table stakes for institutional contracts. Companies without these capabilities are increasingly shut out of RFPs.
• Dispatch automation. Companies that have moved from phone/radio dispatch to automated dispatch systems can handle 3-5x the delivery volume with the same dispatch staff. This operational leverage is what makes scaling possible.
• Data and analytics. Companies that can provide clients with delivery performance dashboards, SLA compliance reports, and volume trend analysis retain customers better and command higher rates.

I valued a regional courier last year that had invested $200K in building a proprietary dispatch and tracking platform. That investment was worth far more than $200K at exit — the buyer valued the technology at roughly $500K-$700K because it reduced their integration timeline and gave them a competitive advantage in the acquired company's market.

Fleet Economics and the EV Transition

Fleet composition directly affects margins and, by extension, valuation. The key metrics buyers analyze:

Vehicle type alignment. Cargo vans ($35K-$45K new) for small parcels and specimens, Sprinter-type vans ($50K-$65K) for larger volume routes, and box trucks ($60K-$90K) for freight. Mismatched fleet — running box trucks on parcel routes or vans on routes that need more capacity — signals operational inefficiency.

Owned vs. leased. Owned fleets with reasonable average age (under 5 years for vans) add asset value to the deal. Leased fleets provide flexibility but create ongoing obligations that reduce free cash flow. Most buyers prefer a mix — owned core fleet with leased surge capacity.

Electric vehicle adoption. Companies that have begun transitioning to electric vans (BrightDrop, Ford E-Transit, Mercedes eSprinter) are getting noticed by buyers. The fuel cost savings ($0.04/mile vs. $0.15/mile for gas) and lower maintenance costs improve long-term margins. Amazon is pushing DSPs toward EV adoption, and corporate clients increasingly require sustainability metrics in their logistics RFPs.

The Bottom Line

Courier and last-mile delivery valuations in 2026 range from 2x EBITDA for commodity on-demand services to 7x EBITDA for specialized medical courier operations with long-term contracts. The key differentiators are contract stability, customer diversification, regulatory specialization, and technology adoption. If you're running a courier business and considering an exit, the highest-impact move is shifting your revenue mix toward long-term contracts with institutional clients and investing in the technology infrastructure that institutional buyers expect to see.